Crossmark

Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study

Crossref DOI link: https://doi.org/10.1016/j.medcli.2022.12.021

Published Print: 2023-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kerget, Buğra

Çil, Gizem

Araz, Ömer

Alper, Fatih

Akgün, Metin
License Information

Text and Data Mining valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01
More Information

This article is maintained by: Elsevier

Article Title: Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2022.12.021

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.